Back to Search
Start Over
CD19-directed T cell-engaging antibodies for the treatment of autoimmune disease.
- Source :
-
The Journal of experimental medicine [J Exp Med] 2024 May 06; Vol. 221 (5). Date of Electronic Publication: 2024 Apr 08. - Publication Year :
- 2024
-
Abstract
- Jennifer S. Michaelson, Chief Scientific Officer at Cullinan Oncology, and Patrick A. Baeuerle, scientific advisor to Cullinan Oncology and honorary professor in immunology at Ludwig Maximilians University Munich, discuss the use of CD19-specific T cell-engaging antibody therapies (TCEs) as therapeutics for autoimmune diseases.<br /> (© 2024 Michaelson and Baeuerle.)
Details
- Language :
- English
- ISSN :
- 1540-9538
- Volume :
- 221
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Journal of experimental medicine
- Publication Type :
- Academic Journal
- Accession number :
- 38587494
- Full Text :
- https://doi.org/10.1084/jem.20240499